Arterial inflammation
Showing 1 - 25 of >10,000
HIV Trial in San Diego (Cenicriviroc Mesylate (CVC), Placebo)
Withdrawn
- HIV Infections
- Cenicriviroc Mesylate (CVC)
- Placebo
- (no location specified)
Dec 19, 2022
Inflammation, HIV Infection, Cardiovascular Disease Trial in San Francisco (VB-201, Placebo)
Withdrawn
- Inflammation
- +2 more
- VB-201
- Placebo
-
San Francisco, CaliforniaZuckerberg San Francisco General Hospital
Sep 12, 2022
Cardiovascular Diseases, Atherosclerosis, Inflammation Trial in Ottawa (Colchicine Oral Product, Placebo oral capsule)
Recruiting
- Cardiovascular Diseases
- +3 more
- Colchicine Oral Product
- Placebo oral capsule
-
Ottawa, Ontario, CanadaUniversity of Ottawa Heart Institute
Oct 3, 2022
Immunomodulatory Effects of PCSK9 Inhibition
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- +3 more
- Contrast-enhanced CCTA
- 99mTc-tilmanocept SPECT/CT scanning
-
Boston, MassachusettsMassachusetts General Hospital
Jan 30, 2023
Arterial Stiffness Trial in Vandoeuvre les Nancy cedex (Measure of aortic inflammation)
Completed
- Arterial Stiffness
- Measure of aortic inflammation
-
Vandoeuvre les Nancy cedex, FranceCHRU Nancy
Nov 28, 2023
Use of 99mTc Tilmanocept for Imaging Arterial Inflammation
Completed
- HIV
- Arterial Imaging
-
Boston, MassachusettsMassachusetts General Hospital
Apr 4, 2022
Diabetes, Type 2, Vascular Inflammation Trial in Amsterdam (Atorvastatin 40 Mg Oral Tablet)
Completed
- Diabetes Mellitus, Type 2
- Vascular Inflammation
- Atorvastatin 40 Mg Oral Tablet
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam UMC, location AMC
Feb 7, 2023
Hepatocellular Carcinoma, Transcatheter Arterial Chemoembolization, Pain Trial in Nanjing (Oxycodone, Sufentanil)
Recruiting
- Hepatocellular Carcinoma
- +3 more
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with Nanjing Medical University
Sep 15, 2023
Atherosclerosis of Artery, Coronary Artery Disease, Peripheral Arterial Disease Trial in Seoul (Rivaroxaban 2.5mg)
Recruiting
- Atherosclerosis of Artery
- +3 more
- Rivaroxaban 2.5mg
-
Seoul, Korea, Republic ofAsan Medical Center
Apr 2, 2023
Ultrasound Markers of Systemic Inflammation
Completed
- Inflammation Process
- +4 more
- Ultrasound measurement
-
Osijek, CroatiaSlavica Kvolik
Mar 22, 2023
HIV-1-infection Trial in United States (CVC 150 mg, CVC 300 mg, Placebo for CVC 150 mg)
Not yet recruiting
- HIV-1-infection
- CVC 150 mg
- +3 more
-
Los Angeles, California
- +16 more
Nov 22, 2022
Arterial Inflammation Trial in Los Angeles (No drug or device, only a test. The test is called a PET/CT)
Recruiting
- Arterial Inflammation
- No drug or device, only a test. The test is called a PET/CT
-
Los Angeles, CaliforniaUCaliforniaLA
Mar 9, 2021
Aortic Infections and Inflammations, Mycotic Aneurysm, Arterial Infections and Inflammations Trial in Vandoeuvre Les Nancy
Not yet recruiting
- Aortic Infections and Inflammations
- +3 more
-
Vandoeuvre Les Nancy, Lorraine, FranceUniversité de Lorraine, CHRU Nancy and APEMAC
Dec 19, 2022
Inflammatory Bowel Disease and Atherosclerosis Development
Recruiting
- Inflammatory Bowel Diseases
- +3 more
-
Moscow, Russian FederationUniversity Hospital #1
Mar 12, 2023
Peripheral Artery Disease (D058729), Oxidative Stress (D018384), Inflammation (D007249) Trial in Salt Lake City (PB125, Placebo,
Not yet recruiting
- Peripheral Artery Disease (D058729)
- +2 more
- PB125
- +2 more
-
Salt Lake City, Utah
- +1 more
Dec 8, 2022
Atherosclerosis of Artery, Peripheral Artery Disease, Diabetes Trial in Changsha, Jinan (N-acetylcysteine, Placebo)
Withdrawn
- Atherosclerosis of Artery
- +4 more
- N-acetylcysteine
- Placebo
-
Changsha, Hunan, China
- +1 more
Jun 9, 2023
Venous Thromboembolism, covid19, Thrombosis Trial in Ryazan' (standard of care anticoagulation in absence of thrombotic
Recruiting
- Venous Thromboembolism
- +2 more
- standard of care anticoagulation in absence of thrombotic complications
- +2 more
-
Ryazan', Russian FederationRyazan State Medical University
Feb 2, 2022
Peripheral Arterial Disease Trial in San Francisco (Pro-Omega, Omega 3 Fatty Acid)
Completed
- Peripheral Arterial Disease
- Pro-Omega
- Omega 3 Fatty Acid
-
San Francisco, CaliforniaUniversity of California San Francisco
Oct 28, 2021
Oxidative Stress, Endothelial Function, Blood Pressure Trial in Athens (tahini and bread, margarine, cheese and bread)
Not yet recruiting
- Oxidative Stress
- +5 more
- tahini and bread
- margarine, cheese and bread
-
Athens, GreecePanagiotis Kanellos
Aug 4, 2022
The Expression and Significance of MiRNA
Completed
- Pulmonary Arterial Hypertension
-
Columbus, OhioThe Ohio State University
Oct 27, 2021
Acute Coronary Syndrome, Lipoproteinemia, Inflammation Trial in Ljubljana (Pelacarsen (TQJ230), Placebo)
Withdrawn
- Acute Coronary Syndrome
- +3 more
- Pelacarsen (TQJ230)
- Placebo
-
Ljubljana, SloveniaUniversity Medical Centre Ljubljana-Department of Vascular disea
Dec 10, 2021
Shock, Cardiogenic, Extra-Corporeal-Life-Support ( ECLS), Autonomic Nervous System Diseases Trial in Nancy (Biological)
Recruiting
- Shock, Cardiogenic
- +3 more
- Biological
-
Nancy, FranceCHRU Nancy
Feb 24, 2022
Peripheral Arterial Disease, Atherosclerosis of Extremities, Inflammation Trial in Hamilton (Colchicine 0.5 MG Oral Tablet,
Recruiting
- Peripheral Arterial Disease
- +2 more
- Colchicine 0.5 MG Oral Tablet
- Colchicine-Placebo
-
Hamilton, Ontario, CanadaHamilton General Hospital
Sep 14, 2021
Obesity, Childhood, Obesity, Endothelial Dysfunction Trial in Brussels (Anthropometry, Blood pressure, Peripheral arterial
Active, not recruiting
- Obesity, Childhood
- +4 more
- Anthropometry
- +4 more
-
Brussels, BelgiumUniversity Hospital of Brussels
May 3, 2021